Abstract
Background: Recent advances in proteomics methodologies allow for high throughput profiling of proteolytic cleavage events. The resulting substrate peptide distributions provide deep insights in the underlying macromolecular recognition events, as determinants of biomolecular specificity identified by proteomics approaches may be compared to structure-based analysis of corresponding protein-protein interfaces.
Method: Here, we present an overview of experimental and computational methodologies and tools applied in the area and provide an outlook beyond the protein class of proteases. Results and Conclusion: We discuss here future potential, synergies and needs of the emerging overlap disciplines of proteomics and structure-based modelling.Keywords: Macromolecular recognition, molecular modelling, peptide binding, protein-protein-interface, protease substrate profiling, specificity.
Graphical Abstract
Current Protein & Peptide Science
Title:Determinants of Macromolecular Specificity from Proteomics-Derived Peptide Substrate Data
Volume: 18 Issue: 9
Author(s): Julian E. Fuchs*, Oliver Schilling and Klaus R. Liedl
Affiliation:
- Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW,United Kingdom
Keywords: Macromolecular recognition, molecular modelling, peptide binding, protein-protein-interface, protease substrate profiling, specificity.
Abstract: Background: Recent advances in proteomics methodologies allow for high throughput profiling of proteolytic cleavage events. The resulting substrate peptide distributions provide deep insights in the underlying macromolecular recognition events, as determinants of biomolecular specificity identified by proteomics approaches may be compared to structure-based analysis of corresponding protein-protein interfaces.
Method: Here, we present an overview of experimental and computational methodologies and tools applied in the area and provide an outlook beyond the protein class of proteases. Results and Conclusion: We discuss here future potential, synergies and needs of the emerging overlap disciplines of proteomics and structure-based modelling.Export Options
About this article
Cite this article as:
Fuchs E. Julian*, Schilling Oliver and Liedl R. Klaus, Determinants of Macromolecular Specificity from Proteomics-Derived Peptide Substrate Data, Current Protein & Peptide Science 2017; 18 (9) . https://dx.doi.org/10.2174/1389203717666160724211231
DOI https://dx.doi.org/10.2174/1389203717666160724211231 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patented Biomarker Panels in Early Detection of Cancer
Recent Patents on Biomarkers Effects of Some Metal Ions on Human Erythrocyte Glutathione Reductase:An In Vitro Study
Protein & Peptide Letters A QSAR Analysis of 2-phenoxy-N-substituted Acetamide Analogues as Hypoxia-Inducible Factor-1(HIF-1) Inhibitors: A Rational Approach to Anticancer Drug Design
Medicinal Chemistry Chemistry in the Bioactivity of Chlorophylls: An Overview
Current Medicinal Chemistry Editorial (Hot Topic: miRNA in the Pathogenesis and Therapy for Gastrointestinal and Hepatic Cancers)
Current Pharmaceutical Design Socioeconomic Consequences of Cervical Cancer: A Narrative Review
Current Women`s Health Reviews n-3 Polyunsaturated Fatty Acids and the Prevention of Colorectal Cancer: Molecular Mechanisms Involved
Current Medicinal Chemistry Rheb/mTOR Activation and Regulation in Cancer: Novel Treatment Strategies beyond Rapamycin
Current Drug Targets A Rationale for the Use of Proton Pump Inhibitors as Antineoplastic Agents
Current Pharmaceutical Design Assessment of miR-212 and Other Biomarkers in the Diagnosis and Treatment of HBV-infection-related Liver Diseases
Current Drug Metabolism HSV Amplicon Vectors for Cancer Therapy
Current Gene Therapy Editorial [Hot Topic: Ion Channels and Cancers (Guest Editor: Robert Kiss)]
Current Medicinal Chemistry The Metabolite Trimethylamine-N-Oxide is an Emergent Biomarker of Human Health
Current Medicinal Chemistry Metabolic Targets of Cardiac HormonesTherapeutic Anti-Cancer Effects
Current Pharmaceutical Design Flavonoids in Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Advances in Drug Safety
Current Pharmaceutical Design Precise Analysis of the Autofluorescence Characteristics of Rat Colon Under UVA and Violet Light Excitation
Current Pharmaceutical Biotechnology Preface
Current Proteomics Human Papillomavirus (HPV) Vaccines as an Option for Preventing Cervical Malignancies: (How) Effective and Safe?
Current Pharmaceutical Design Recent Advances on the Network Models in Target-based Drug Discovery
Current Topics in Medicinal Chemistry